Both anti-CD81 and anti-Beta-1 integrin antibodies promoted hepatoma spread in a time dependent manner (Figure 1), whereas cells failed to attach or spread on isotype control IgG coated plates. Here, CD81 is linked to hepatocellular carcinoma.